HIV/AIDS Clinical Trials Network Leadership and Operations Centers (UM1 Clinical Trial Required)
Open Posted
- Opportunity number
- RFA-AI-28-001
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.8RP National Institute of Allergy and Infectious Diseases- Research Projects
- 93.DA1 Drug Use and Addiction Research Programs - Research Projects
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- 93.HL2 National Heart, Lung, and Blood Institute - Research Projects
- 93.AGR National Institute on Aging Research Projects
- 93.DE1 Oral Diseases and Disorders Research -Research Projects
- 93.HDR Child Health and Human Development Extramural Research Projects
- 93.KRC Diabetes, Digestive, Kidney Extramural Research - Research Centers
- 93.242 Mental Health Research Grants
- 93.310 Trans-NIH Research Support
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Higher Education Inst. (Public)
- Tribal Organizations (Not Federally Recognized)
- State Governments
- City/Township Governments
- Other
- Small Businesses
- County Governments
- 501(c)(3) Nonprofits
- For Profit Organizations
- Non-501(c)(3) Nonprofits
- Higher Education Inst. (Private)
- Public or Indian Housing Auth.
- Special District Governments
- Independent School Districts
- Tribal Governments (Federally Recognized)
- Points of contact
Opportunity details come from Grants.gov. Updated .
About this opportunity
NIAID, part of the National Institutes of Health, is forecasting a cooperative agreement NOFO (RFA-AI-28-001) to fund four HIV/AIDS Clinical Trials Network Leadership and Operations Centers (LOCs), with applications due February 9, 2027 at 5:00 PM local time. The attached full announcement sets this date, superseding the March 9, 2027 due date in the opportunity record. Only applications proposing clinical trials are eligible, and foreign organizations cannot serve as primary applicants.
Eligible applicants include public and private higher education institutions; state, county, city/township, and special district governments; federally recognized and non-federally recognized tribal governments and tribal organizations; public and Indian housing authorities; independent school districts; small businesses; for-profit organizations; and 501(c)(3) and non-501(c)(3) nonprofits. Other eligible applicants include eligible federal agencies, U.S. territories or possessions, faith-based or community-based organizations, and regional organizations. Cost sharing is not required.
NIAID estimates $48 million total to fund four awards in FY2028, each with a 7-year project period, an anticipated earliest start date of July 2027, and anticipated awards in October 2027 and December 2027. Each LOC develops the research agenda for one area: HIV therapeutics/cure and prevention/treatment of HIV-associated comorbidities in adults; HIV prevention/treatment in maternal, adolescent, and pediatric populations; biomedical HIV prevention for adults and adolescents; and immune-based prevention for HIV and HIV-associated diseases. Each LOC coordinates with Laboratory Centers, Statistical and Data Management Centers, and Clinical Trials Units.
Applications undergo dual peer review for scientific and technical merit, followed by advisory council review. The source assigns no criteria weighting. The Research Strategy comprises nine subsections, including an LOC overview and clinical research agenda of 12 to 30 pages each, plus governance, training, evaluation metrics, quality management, clinical operations, collaboration, and community engagement. Applicants must demonstrate experience managing complex clinical research programs, protocol design, regulatory compliance, and site selection. Registration requires SAM, eRA Commons, Grants.gov, and ORCID. Recipients must comply with 21 CFR Part 11, ICH E6, and DAIDS clinical research policies.
The NOFO is assigned to eleven NIH assistance listings: 93.310, 93.242, 93.855, 93.853, 93.HDR, 93.AGR, 93.DE1, 93.8RP, 93.DA1, 93.HL2, and 93.KRC. Authorities cited are Sections 301 and 405 of the Public Health Service Act, 42 CFR Part 52, and 2 CFR Part 200.
Synopsis
The purpose of this notice of funding opportunity (NOFO) is to support HIV/AIDS Clinical Trials Network Leadership and Operations Centers (LOCs). Each LOC will oversee research prioritization, planning, and conduct of studies in a HIV/AIDS Clinical Trials Network to advance research in the prevention and treatment of HIV and HIV-associated diseases.
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
Files
| File | Type | Posted |
|---|---|---|
| PKG00294600.pdf | ||
| RFA-AI-28-001-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity